Literature DB >> 16766634

Selective spatiotemporal induction of matrix metalloproteinase-2 and matrix metalloproteinase-9 transcription after myocardial infarction.

Rupak Mukherjee1, Joseph T Mingoia, James A Bruce, Jeffrey S Austin, Robert E Stroud, G Patricia Escobar, David M McClister, Claire M Allen, Maria A Alfonso-Jaume, M Elizabeth Fini, David H Lovett, Francis G Spinale.   

Abstract

Myocardial remodeling after myocardial infarction (MI) is associated with increased levels of the matrix metalloproteinases (MMPs). Levels of two MMP species, MMP-2 and MMP-9, are increased after MI, and transgenic deletion of these MMPs attenuates post-MI left ventricular (LV) remodeling. This study characterized the spatiotemporal patterns of gene promoter induction for MMP-2 and MMP-9 after MI. MI was induced in transgenic mice in which the MMP-2 or MMP-9 promoter sequence was fused to the beta-galactosidase reporter, and reporter level was assayed up to 28 days after MI. Myocardial localization with respect to cellular sources of MMP-2 and MMP-9 promoter induction was examined. After MI, LV diameter increased by 70% (P < 0.05), consistent with LV remodeling. beta-Galactosidase staining in MMP-2 reporter mice was increased by 1 day after MI and increased further to 64 +/- 6% of LV epicardial area by 7 days after MI (P < 0.05). MMP-2 promoter activation occurred in fibroblasts and myofibroblasts in the MI region. In MMP-9 reporter mice, promoter induction was detected after 3 days and peaked at 7 days after MI (53 +/- 6%, P < 0.05) and was colocalized with inflammatory cells at the peri-infarct region. Although MMP-2 promoter activation was similarly distributed in the MI and border regions, activation of the MMP-9 promoter was highest at the border between the MI and remote regions. These unique findings visually demonstrated that activation of the MMP-2 and MMP-9 gene promoters occurs in a distinct spatial relation with reference to the MI region and changes in a characteristic time-dependent manner after MI.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16766634     DOI: 10.1152/ajpheart.01343.2005

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  42 in total

1.  Spatiotemporal induction of matrix metalloproteinase-9 transcription after discrete myocardial injury.

Authors:  Rupak Mukherjee; Gregory P Colbath; Charles D Justus; James A Bruce; Claire M Allen; Kenneth W Hewett; J Philip Saul; Robert G Gourdie; Francis G Spinale
Journal:  FASEB J       Date:  2010-06-08       Impact factor: 5.191

Review 2.  Temporal and spatial expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases following myocardial infarction.

Authors:  Merry L Lindsey; Rogelio Zamilpa
Journal:  Cardiovasc Ther       Date:  2010-07-14       Impact factor: 3.023

3.  Cardiac restricted overexpression of membrane type-1 matrix metalloproteinase causes adverse myocardial remodeling following myocardial infarction.

Authors:  Francis G Spinale; Rupak Mukherjee; Juozas A Zavadzkas; Christine N Koval; Shenikqua Bouges; Robert E Stroud; Lawrence W Dobrucki; Albert J Sinusas
Journal:  J Biol Chem       Date:  2010-07-19       Impact factor: 5.157

Review 4.  Matrix metalloproteinases as input and output signals for post-myocardial infarction remodeling.

Authors:  Merry L Lindsey; Rugmani Padmanabhan Iyer; Mira Jung; Kristine Y DeLeon-Pennell; Yonggang Ma
Journal:  J Mol Cell Cardiol       Date:  2015-12-23       Impact factor: 5.000

Review 5.  Imaging of matrix metalloproteinase activation and left ventricular remodeling.

Authors:  Grace Chung; Albert J Sinusas
Journal:  Curr Cardiol Rep       Date:  2007-04       Impact factor: 2.931

6.  Short-term disruption in regional left ventricular electrical conduction patterns increases interstitial matrix metalloproteinase activity.

Authors:  Rupak Mukherjee; Juozas A Zavadzkas; William T Rivers; Julie E McLean; Eileen I Chang; Shenikqua Bouges; Robert G Matthews; Christine N Koval; Robert E Stroud; Francis G Spinale
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-05-14       Impact factor: 4.733

7.  Dor procedure for dyskinetic anteroapical myocardial infarction fails to improve contractility in the border zone.

Authors:  Kay Sun; Zhihong Zhang; Takamaro Suzuki; Jonathan F Wenk; Nielen Stander; Daniel R Einstein; David A Saloner; Arthur W Wallace; Julius M Guccione; Mark B Ratcliffe
Journal:  J Thorac Cardiovasc Surg       Date:  2010-03-17       Impact factor: 5.209

8.  Targeted myocardial microinjections of a biocomposite material reduces infarct expansion in pigs.

Authors:  Rupak Mukherjee; Juozas A Zavadzkas; Stuart M Saunders; Julie E McLean; Laura B Jeffords; Christy Beck; Robert E Stroud; Allyson M Leone; Christine N Koval; William T Rivers; Shubhayu Basu; Alexander Sheehy; Gene Michal; Francis G Spinale
Journal:  Ann Thorac Surg       Date:  2008-10       Impact factor: 4.330

9.  ZAK induces MMP-2 activity via JNK/p38 signals and reduces MMP-9 activity by increasing TIMP-1/2 expression in H9c2 cardiomyoblast cells.

Authors:  Yi-Chang Cheng; Wei-Wen Kuo; Hsi-Chin Wu; Tung-Yuan Lai; Chun-Hsien Wu; Jin-Ming Hwang; Wen-Hong Wang; Fuu-Jen Tsai; Jaw-Ji Yang; Chih-Yang Huang; Chun-Hsien Chu
Journal:  Mol Cell Biochem       Date:  2009-01-28       Impact factor: 3.396

10.  Left ventricular myocardial contractility is depressed in the borderzone after posterolateral myocardial infarction.

Authors:  Rafael Shimkunas; Zhihong Zhang; Jonathan F Wenk; Mehrdad Soleimani; Michael Khazalpour; Gabriel Acevedo-Bolton; Guanying Wang; David Saloner; Rakesh Mishra; Arthur W Wallace; Liang Ge; Anthony J Baker; Julius M Guccione; Mark B Ratcliffe
Journal:  Ann Thorac Surg       Date:  2013-03-21       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.